Bicycle Therapeutics Announces First US Appointment
Bicycle Therapeutics, the UK-based biotechnology company, has appointed Rosamond Deegan president and chief of business of its newly established US operation, headquartered in Cambridge, Massachusetts. Deegan joins Bicycle Therapeutics from Trevena Inc., where she was most recently senior vice president, business development and operations, before which she was head of finance and operations. Prior to her time at Trevena, Deegan held a number of positions at GlaxoSmithKline, both in the US and the UK.
Register for our free email digests: